36 results on '"Mæng, Michael"'
Search Results
2. Relationship between coronary volume, myocardial mass, and post‐PCI fractional flow reserve
3. Early healing after treatment of coronary lesions by thin strut everolimus, or thicker strut biolimus eluting bioabsorbable polymer stents: The SORT‐OUT VIII OCT study
4. Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
5. Balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension previously operated by pulmonary endarterectomy
6. Microvascular disease increases the risk of lower limb amputation – A Western Danish cohort study
7. Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
8. Impact of diabetes on 1‐year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial
9. CHA 2 DS 2 ‐VASc impact on risk following percutaneous coronary intervention in atrial fibrillation
10. Rationale and design of the precise percutaneous coronary intervention plan ( P3 ) study: Prospective evaluation of a virtual computed tomography‐based percutaneous intervention planner
11. Research update for articles published in EJCI in 2017
12. Predicting stroke in patients without atrial fibrillation
13. Quantitative flow ratio for immediate assessment of nonculprit lesions in patients with ST‐segment elevation myocardial infarction—An iSTEMI substudy
14. Coronary stent implantation and adverse cardiac events after surgery
15. Impact of diabetes on clinical outcomes after revascularization with sirolimus‐eluting and biolimus‐eluting stents with biodegradable polymer from the SORT OUT VII trial
16. Development of heart failure in patients with rheumatoid arthritis: A Danish population-based study
17. Coronary artery disease and risk of adverse cardiac events and stroke
18. A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the diabedES IV randomized angiography trial)
19. Treatment of Patients with STEMI
20. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: From Western Denmark heart registry
21. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: The randomized diabetes and drug-eluting stent (DiabeDES) IV intravascular ultrasound trial
22. Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with ST-segment elevation myocardial infarction: From the Western Denmark heart registry
23. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: From Western Denmark heart registry
24. Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation
25. Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy
26. Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events
27. The impact of acquisition angle differences on three‐dimensional quantitative coronary angiography
28. Nonsteroidal Antiinflammatory Drug Use and Cardiovascular Risks After Coronary Stent Implantation
29. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention
30. Acute haemodynamic effects of erythropoietin alone and in combination with dopamine in a porcine model
31. Lack of acute cardioprotective effect from preischaemic erythropoietin administration in a porcine coronary occlusion model
32. Catheter‐based 32P β‐radiation after stent implantation in porcine coronary arteries: Role of source‐centering and geographical miss
33. Ten-year clinical outcomes after drug-eluting stents implantation according to clinical presentation-Insights from the DECADE cooperation.
34. CHA 2 DS 2 -VASc impact on risk following percutaneous coronary intervention in atrial fibrillation.
35. Randomized Comparison of Terumo® Coated Slender™ versus Terumo® Noncoated Traditional Sheath during Radial Angiography or Percutaneous Coronary Intervention.
36. Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.